Keyphrases
Acute Pain Episodes
100%
Antiplatelet Agents
5%
CD40 Ligand (CD40L)
8%
Chronic Inflammation
8%
Coagulation Activation
8%
Disease Complications
5%
Endothelial Activation Markers
5%
Eptifibatide
50%
Gentle Hydration
5%
Glycoprotein IIb/IIIa Inhibitors
5%
Hypercoagulability
5%
Inflammatory Mediators
5%
Leukocyte Proliferation
5%
Pathophysiology
5%
Patient Relatives
5%
Platelet Activation
16%
Platelet-leukocyte Aggregates
5%
Platelets
5%
Sickle Cell Disease
50%
Steady State
8%
Supplemental Oxygen
5%
Medicine and Dentistry
Antiplatelet Drug
7%
CD40 Ligand
10%
Chronic Inflammation
10%
Eptifibatide
50%
Glycoprotein IIb/IIIa Inhibitors
7%
Leukocyte
7%
Narcotic Analgesic Agent
7%
Pain
50%
Pathophysiology
7%
Patient with Sickle Cell Disease
10%
Platelet
14%
Sickle-Cell Disease
50%
Steady State
10%
Thrombocyte Activation
14%
Thrombocyte Function
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antithrombocytic Agent
5%
CD40 Ligand
8%
Chronic Inflammation
8%
Eptifibatide
50%
Fibrinogen Receptor
5%
Inflammation
8%
Pain
50%
Pathophysiology
5%
Sickle Cell Anemia
50%